Chris Storgard's most recent trade in Design Therapeutics Inc was a trade of 250,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Design Therapeutics Inc | Chris Storgard | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 250,000 | 250,000 | - | - | Stock option (right to buy) | |
| Design Therapeutics Inc | Chris Storgard | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 400,000 | 400,000 | - | - | Stock Option (right to buy) |